David T. Howard
No más puestos en curso
Perfil
David T.
Howard held several positions in various companies throughout his career.
He was the Chairman and Chief Executive Officer of SCOLR Pharma, Inc. from 2000 to 2005, Chairman of Angiotech Pharmaceuticals, Inc. from 2000 to 2011, and Chairman of Luminor Medical Technologies, Inc. from 2011 to 2012.
He also served as a Director in several companies such as VIA Pharmaceuticals, Inc., biOasis Technologies, Inc., and Calyx Ventures, Inc. Additionally, he was the President of Novopharm USA, Inc. and Novopharm International, and Vice President-Pharmaceuticals of Boehringer Mannheim Canada Ltd.
Howard received his undergraduate degree from the University of Saskatchewan.
Antiguos cargos conocidos de David T. Howard.
| Empresas | Cargo | Fin |
|---|---|---|
| CALYX VENTURES INC. | Director/Miembro de la Junta | 16/12/2014 |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Presidente | 16/04/2012 |
| BIOASIS TECHNOLOGIES INC. | Director/Miembro de la Junta | 24/06/2011 |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Presidente | 12/05/2011 |
| SCOLR PHARMA INC. | Presidente | 01/06/2005 |
Formación de David T. Howard.
| University of Saskatchewan | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| VIA PHARMACEUTICALS, INC. | Health Technology |
| BIOASIS TECHNOLOGIES INC. | Health Technology |
| CALYX VENTURES INC. | Technology Services |
| Empresas privadas | 11 |
|---|---|
SCOLR Pharma, Inc.
 SCOLR Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCOLR Pharma, Inc. is a pharmaceutical company, engages in proprietary and patented Controlled Delivery Technology platforms to develop and commercialize novel prescription, over-the-counter and nutritional products. The company's technology is used to develop dietary supplement products, including combinations of glucosamine and chondroitin, niacin, calcium, and other dietary products. Its lead product candidate is a CDT-based extended release formulation of ibuprofen, an analgesic typically used for the treatment of pain, fever and inflammation. SCOLR Pharma was founded in 1983 and is headquartered in Bellevue, WA. | Health Technology |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
SMC Ventures, Inc.
 SMC Ventures, Inc. Miscellaneous Commercial ServicesCommercial Services SMC Ventures, Inc. engaged in the provision of management consulting services. The company was founded in 1980 and is headquartered in Vancouver, Canada. | Commercial Services |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Commercial Services |
SemBioSys Genetics, Inc.
 SemBioSys Genetics, Inc. BiotechnologyHealth Technology SemBioSys Genetics, Inc. operates as a plant-based technology development company, which engages in the manufacturing technology platforms to develop, manufacture and commercialize healthy living, animal health and pharmaceutical products. It offers proteins, functional food and nutritional products. The company was founded by Maurice Moloney on April 25, 1994 and is headquartered in Calgary, Canada. | Health Technology |
MSI Methylation Sciences, Inc.
 MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Health Technology |
Richardson International Ltd.
 Richardson International Ltd. Wholesale DistributorsDistribution Services Richardson International Ltd. operates as an agricultural and food industry company. It offers production, facility management, logistics, product sourcing, and processing. The company was founded by James A. Richardson in 1857 and is headquartered in Winnipeg, Canada. | Distribution Services |
| 159230 Canada, Inc. | |
| Novopharm USA, Inc. | |
| Novopharm International | |
| Boehringer Mannheim Canada Ltd. |
- Bolsa de valores
- Insiders
- David T. Howard
